11,437
Total Claims
$2.0M
Drug Cost
1,245
Beneficiaries
$1,616
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+6%
Cost per patient vs peers
$1,616 vs $1,524 avg
-4%
Brand preference vs peers
13.1% vs 13.7% avg
Brand vs Generic
87% generic
Brand: 1,503 claims · $1.8M
Generic: 9,934 claims · $255K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 922 | $1.2M |
| Rivaroxaban | 174 | $199K |
| Alirocumab | 124 | $114K |
| Evolocumab | 79 | $81K |
| Sacubitril/Valsartan | 55 | $65K |
| Rosuvastatin Calcium | 1,278 | $46K |
| Ezetimibe | 873 | $37K |
| Empagliflozin | 28 | $32K |
| Atorvastatin Calcium | 885 | $14K |
| Atenolol | 992 | $10K |
| Torsemide | 427 | $8,718 |
| Midodrine Hcl | 69 | $7,135 |
| Chlorthalidone | 261 | $6,818 |
| Losartan Potassium | 420 | $5,772 |
| Valsartan | 199 | $5,664 |
Prescribing Profile
63
Unique Drugs
$1.5M
Patient Profile
76
Avg Age
47%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About